Andrew J. Mills - 16 Dec 2025 Form 4 Insider Report for Medline Inc. (MDLN)

Role
Director
Signature
/s/ Nicole Fritz, Attorney-in-Fact
Issuer symbol
MDLN
Transactions as of
16 Dec 2025
Net transactions value
+$74,999,974
Form type
4
Filing time
22 Dec 2025, 16:30:06 UTC
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mills Andrew J. Director C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD /s/ Nicole Fritz, Attorney-in-Fact 22 Dec 2025 0001460212

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDLN Class B Common Stock Award +30,655 30,655 16 Dec 2025 See Footnote F1, F2
transaction MDLN Class A Common Stock Purchase $74,999,974 +2,586,206 $29.00 2,586,206 18 Dec 2025 See Footnote F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDLN Common Units of Medline Holdings, LP Award +30,655 30,655 16 Dec 2025 Class A Common Stock 30,655 See Footnote F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025.
F2 These securities are held by a trust for the benefit of the Reporting Person and members of his immediate family, and of which the Reporting Person has the power to replace the trustee. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 Reflects shares of Class A Common Stock of the Issuer acquired in the initial public offering of Class A Common Stock of the Issuer at the initial public offering price and on the same terms as the other purchasers in the initial public offering.
F4 These securities are held for the benefit of the Reporting Person and members of his immediate family by a limited liability company. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F5 Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP for shares of the Issuer's Class A common stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.